Thomas A. Wadden

73.9k total citations · 27 hit papers
481 papers, 50.6k citations indexed

About

Thomas A. Wadden is a scholar working on Clinical Psychology, Pharmacy and Physiology. According to data from OpenAlex, Thomas A. Wadden has authored 481 papers receiving a total of 50.6k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Clinical Psychology, 170 papers in Pharmacy and 142 papers in Physiology. Recurrent topics in Thomas A. Wadden's work include Eating Disorders and Behaviors (195 papers), Obesity and Health Practices (170 papers) and Pharmacology and Obesity Treatment (119 papers). Thomas A. Wadden is often cited by papers focused on Eating Disorders and Behaviors (195 papers), Obesity and Health Practices (170 papers) and Pharmacology and Obesity Treatment (119 papers). Thomas A. Wadden collaborates with scholars based in United States, Denmark and Canada. Thomas A. Wadden's co-authors include Gary D. Foster, David B. Sarwer, Albert J. Stunkard, Adam Gilden Tsai, Steven B. Heymsfield, Meghan L. Butryn, Kelly D. Brownell, John M. Jakicic, Robert F. Kushner and Anthony N. Fabricatore and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Thomas A. Wadden

476 papers receiving 48.2k citations

Hit Papers

2013 AHA/ACC/TOS Guideline for t... 1992 2026 2003 2014 2013 2021 2013 2013 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
    2013 3.1k citations Michael D. Jensen, Donna H. Ryan et al. profile →
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity
    2021 2.5k citations Rachel L. Batterham, Barbara McGowan et al. profile →
  3. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
    2013 1.9k citations Michael D. Jensen, Donna H. Ryan et al. Circulation profile →
  4. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
    2013 1.7k citations Robert H. Eckel, John M. Jakicic et al. Circulation profile →
  5. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
    2011 1.3k citations Rena R. Wing, Thomas A. Wadden et al. profile →
  6. Mechanisms, Pathophysiology, and Management of Obesity
    2017 1.3k citations Thomas A. Wadden et al. profile →
  7. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
    2013 872 citations John M. Jakicic, Jamy D. Ard et al. profile →
  8. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
    2021 806 citations Thomas A. Wadden et al. profile →
  9. The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
    2006 667 citations Thomas A. Wadden, John M. Jakicic et al. Obesity profile →
  10. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
    2021 646 citations Thomas A. Wadden, Juan P. Frías et al. JAMA profile →
  11. Binge eating disorder: Its further validation in a multisite study
    1993 632 citations Susan Z. Yanovski, Thomas A. Wadden et al. International Journal of Eating Disorders profile →
  12. Binge eating disorder: A multisite field trial of the diagnostic criteria
    1992 614 citations Rena R. Wing, Thomas A. Wadden et al. International Journal of Eating Disorders profile →
  13. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
    2013 610 citations Thomas A. Wadden et al. International Journal of Obesity profile →
  14. The Science of Obesity Management: An Endocrine Society Scientific Statement
    2018 559 citations Michael D. Jensen, Robert F. Kushner et al. profile →
  15. Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
    2005 556 citations Thomas A. Wadden, Robert I. Berkowitz et al. profile →
  16. Primary Care Physicians’ Attitudes about Obesity and Its Treatment
    2003 540 citations Gary D. Foster, Thomas A. Wadden et al. profile →
  17. Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States
    2005 519 citations Thomas A. Wadden et al. profile →
  18. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
    2022 515 citations Rachel L. Batterham, Kristian Kandler et al. profile →
  19. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
    2022 469 citations W. Timothy Garvey, Rachel L. Batterham et al. Nature Medicine profile →
  20. Lifestyle Modification for Obesity
    2012 414 citations Thomas A. Wadden et al. Circulation profile →
  21. A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice
    2011 381 citations Thomas A. Wadden, David B. Sarwer et al. profile →
  22. Lifestyle modification approaches for the treatment of obesity in adults.
    2020 360 citations Thomas A. Wadden, Meghan L. Butryn et al. profile →
  23. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
    2016 356 citations Gary D. Foster, Gary Zammit et al. International Journal of Obesity profile →
  24. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
    2023 220 citations Thomas A. Wadden, Ariana M. Chao et al. Nature Medicine profile →
  25. Dietary interventions for obesity: clinical and mechanistic findings
    2021 150 citations Ariana M. Chao, Thomas A. Wadden et al. profile →
  26. Nutritional considerations with antiobesity medications
    2024 54 citations Thomas A. Wadden, Colleen Tewksbury et al. Obesity profile →
  27. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
    2025 37 citations W. Timothy Garvey, Thomas A. Wadden et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Wadden United States 107 16.8k 15.4k 14.6k 11.8k 11.0k 481 50.6k
Rena R. Wing United States 104 14.9k 0.9× 16.2k 1.0× 19.8k 1.4× 8.7k 0.7× 7.4k 0.7× 649 47.1k
Jack A. Yanovski United States 86 8.1k 0.5× 8.6k 0.6× 10.4k 0.7× 4.2k 0.4× 5.2k 0.5× 428 31.3k
James O. Hill United States 89 18.6k 1.1× 6.8k 0.4× 17.9k 1.2× 4.0k 0.3× 5.1k 0.5× 433 40.5k
Donna H. Ryan United States 68 10.1k 0.6× 3.2k 0.2× 7.2k 0.5× 3.5k 0.3× 6.6k 0.6× 249 24.9k
John M. Jakicic United States 73 13.4k 0.8× 4.4k 0.3× 10.0k 0.7× 2.9k 0.2× 3.3k 0.3× 332 28.3k
Arne Astrup Denmark 112 24.9k 1.5× 3.4k 0.2× 15.4k 1.1× 1.4k 0.1× 11.5k 1.0× 837 51.1k
Jacob C. Seidell Netherlands 99 12.7k 0.8× 2.6k 0.2× 14.9k 1.0× 3.2k 0.3× 6.5k 0.6× 501 37.2k
Lars Sjöström Sweden 79 12.5k 0.7× 2.4k 0.2× 3.9k 0.3× 3.6k 0.3× 7.9k 0.7× 238 28.5k
Robert F. Kushner United States 59 9.5k 0.6× 1.9k 0.1× 4.2k 0.3× 3.4k 0.3× 5.8k 0.5× 233 22.8k
Johan G. Eriksson Finland 92 11.1k 0.7× 1.8k 0.1× 10.9k 0.7× 2.0k 0.2× 12.0k 1.1× 839 46.7k

Countries citing papers authored by Thomas A. Wadden

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Wadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Wadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Wadden more than expected).

Fields of papers citing papers by Thomas A. Wadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Wadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Wadden. The network helps show where Thomas A. Wadden may publish in the future.

Co-authorship network of co-authors of Thomas A. Wadden

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Wadden. A scholar is included among the top collaborators of Thomas A. Wadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Wadden. Thomas A. Wadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kushner, Robert F., Jamy D. Ard, Thomas A. Wadden, et al.. (2025). Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results. International Journal of Obesity. 50(1). 159–165.
2.
Jakicic, John M., Donna H. Ryan, Jamy D. Ard, et al.. (2025). Association of the Early Response to an Oral Shape‐Shifting Superabsorbent Hydrogel Capsule With Weight Loss. Clinical Obesity. 16(1). e70037–e70037. 2 indexed citations
3.
Ard, Jamy D., Donna H. Ryan, Patrick M. O’Neil, et al.. (2025). Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study. Obesity. 33(3). 500–511. 5 indexed citations
4.
Wadden, Thomas A., et al.. (2024). Longitudinal associations of internalized weight stigma with physical activity and weight loss. Obesity Science & Practice. 10(4). e773–e773. 3 indexed citations
5.
Sarwer, David B., Thomas A. Wadden, Rebecca L. Ashare, et al.. (2024). Psychopathology, disordered eating, and impulsivity as predictors of weight loss 24 months after metabolic and bariatric surgery. Surgery for Obesity and Related Diseases. 20(7). 634–642. 3 indexed citations
6.
Wadden, Thomas A., Ariana M. Chao, Sriram Machineni, et al.. (2024). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Diabetologie und Stoffwechsel. 19(S 01). S83–S84. 1 indexed citations
7.
Kushner, Robert F., Anders Fink‐Jensen, Barbara McGowan, et al.. (2023). Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis. Obesity. 32(2). 273–280. 5 indexed citations
8.
Garvey, W. Timothy, Rachel L. Batterham, Silvio Buscemi, et al.. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 28(10). 2083–2091. 469 indexed citations breakdown →
9.
Garvey, Timothy, Rachel L. Batterham, Silvio Buscemi, et al.. (2022). Wirkung von Semaglutid 2,4 mg vs. Placebo über 2 Jahre bei Erwachsenen mit Adipositas (STEP 5) (#7). 16(3). 168–169.
10.
Kuna, Samuel T., David M. Reboussin, Elsa S. Strotmeyer, et al.. (2020). Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study. American Journal of Respiratory and Critical Care Medicine. 203(2). 221–229. 77 indexed citations
11.
Faulconbridge, Lucy F., Christina M. Hopkins, Chanelle T. Bishop‐Gilyard, et al.. (2018). Combined Treatment for Obesity and Depression: A Pilot Study. Obesity. 26(7). 1144–1152. 35 indexed citations
12.
Alamuddin, Naji, Zayna M. Bakizada, & Thomas A. Wadden. (2016). Management of Obesity. Journal of Clinical Oncology. 34(35). 4295–4305. 51 indexed citations
13.
Alamuddin, Naji & Thomas A. Wadden. (2016). Behavioral Treatment of the Patient with Obesity. Endocrinology and Metabolism Clinics of North America. 45(3). 565–580. 24 indexed citations
14.
McCaffery, Jeanne M., George D. Papandonatos, Lucy F. Faulconbridge, et al.. (2015). Genetic Predictors of Depressive Symptoms in the Look AHEAD Trial. Psychosomatic Medicine. 77(9). 982–992. 5 indexed citations
15.
Jensen, Michael D., Donna H. Ryan, Karen A. Donato, et al.. (2014). Executive summary: Guidelines (2013) for the management of overweight and obesity in adults. Obesity. 22(S2). S5–39. 262 indexed citations
16.
Eckel, Robert H., John M. Jakicic, Jamy D. Ard, et al.. (2013). 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. Circulation. 129(25_suppl_2). 2960–84. 1695 indexed citations breakdown →
17.
Pisapia, Jared M., Casey H. Halpern, Noel N. Williams, et al.. (2010). Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study. Neurosurgical FOCUS. 29(2). E15–E15. 24 indexed citations
18.
Butryn, Meghan L. & Thomas A. Wadden. (2005). Treatment of overweight in children and adolescents: Does dieting increase the risk of eating disorders?. International Journal of Eating Disorders. 37(4). 285–293. 67 indexed citations
19.
Berkowitz, Robert I., et al.. (2003). Behavior Therapy and Sibutramine for the Treatment of Adolescent Obesity. JAMA. 289(14). 1805–1805. 277 indexed citations
20.
Sarwer, David B., Thomas A. Wadden, Michael Pertschuk, & Linton A. Whitáker. (1998). Body Image Dissatisfaction and Body Dysmorphic Disorder in 100 Cosmetic Surgery Patients. Plastic & Reconstructive Surgery. 101(6). 1644–1649. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rena R. Wing Breakdown of academic impact, for papers by Jack A. Yanovski Breakdown of academic impact, for papers by James O. Hill Breakdown of academic impact, for papers by Donna H. Ryan Breakdown of academic impact, for papers by John M. Jakicic Breakdown of academic impact, for papers by Arne Astrup Breakdown of academic impact, for papers by Jacob C. Seidell Breakdown of academic impact, for papers by Lars Sjöström Breakdown of academic impact, for papers by Robert F. Kushner Breakdown of academic impact, for papers by Johan G. Eriksson
Rankless by CCL
2026